Aethlon Financial Statements From 2010 to 2024

AEMD Stock  USD 0.52  0.09  20.84%   
Aethlon Medical financial statements provide useful quarterly and yearly information to potential Aethlon Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aethlon Medical financial statements helps investors assess Aethlon Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aethlon Medical's valuation are summarized below:
Gross Profit
574.2 K
Market Capitalization
6.1 M
Enterprise Value Revenue
1.0661
Revenue
574.2 K
Earnings Share
(2.79)
There are over one hundred nineteen available fundamental signals for Aethlon Medical, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Aethlon Medical's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. As of December 20, 2024, Market Cap is expected to decline to about 4.1 M. The current year's Enterprise Value is expected to grow to about (146.8 K)

Aethlon Medical Total Revenue

0.0

Check Aethlon Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aethlon Medical's main balance sheet or income statement drivers, such as Interest Expense of 158.4 M, Other Operating Expenses of 13.3 M or Total Operating Expenses of 12.9 M, as well as many indicators such as Price To Sales Ratio of 14.85, Dividend Yield of 0.0 or PTB Ratio of 0.79. Aethlon financial statements analysis is a perfect complement when working with Aethlon Medical Valuation or Volatility modules.
  
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Aethlon Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.7 M8.2 M6.3 M
Slightly volatile
Other Current Liabilities723.4 K761.5 K1.6 M
Slightly volatile
Total Current Liabilities2.8 M1.8 M3.3 M
Slightly volatile
CashM5.4 M5.1 M
Slightly volatile
Non Current Assets Total2.4 M2.3 M680.6 K
Slightly volatile
Non Currrent Assets Other326.7 K311.1 K71.7 K
Slightly volatile
Cash And Short Term InvestmentsM5.4 M5.1 M
Slightly volatile
Common Stock Total Equity13.3 K14 K43.3 K
Slightly volatile
Common Stock Shares Outstanding2.6 M2.5 M717.2 K
Slightly volatile
Liabilities And Stockholders Equity8.7 M8.2 M6.3 M
Slightly volatile
Other Stockholder Equity168.4 M160.3 M101.6 M
Slightly volatile
Total Liabilities4.1 M2.5 M3.7 M
Slightly volatile
Total Current Assets3.2 M5.9 M5.5 M
Slightly volatile
Common Stock2.5 K2.6 K42.8 K
Slightly volatile
Property Plant And Equipment NetM1.9 M538.5 K
Slightly volatile
Accounts Payable566 K777.9 K437.6 K
Very volatile
Property Plant And Equipment GrossM2.9 M673.9 K
Slightly volatile
Intangible AssetsK1.1 K63.7 K
Slightly volatile
Short and Long Term Debt Total949.8 K940.3 K1.1 M
Slightly volatile
Current Deferred Revenue183.2 K192.8 K625.7 K
Slightly volatile
Other Assets0.951.064.3 K
Slightly volatile
Other Current Assets480.7 K506 K15.6 M
Pretty Stable
Short Term Debt276 K290.6 K847.7 K
Slightly volatile
Property Plant Equipment2.8 M2.6 M631.4 K
Slightly volatile
Capital Surpluse97.7 M148.7 M96 M
Slightly volatile
Long Term Debt Total620.4 K967.3 K729.5 K
Slightly volatile
Short and Long Term Debt735 K866.1 K1.2 M
Slightly volatile
Net Invested Capital10.6 M5.8 M8.4 M
Slightly volatile
Net Working Capital4.2 M4.4 M7.5 M
Pretty Stable
Capital Stock2.5 K2.6 K15.7 K
Slightly volatile
Capital Lease Obligations673.7 K940.3 K333.7 K
Slightly volatile
Non Current Liabilities Other34 K38.3 K41.7 K
Slightly volatile

Aethlon Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses13.3 M12.6 M7.1 M
Slightly volatile
Total Operating Expenses12.9 M12.3 MM
Slightly volatile
Depreciation And Amortization377 K359.1 K94.3 K
Slightly volatile
Cost Of Revenue341.1 K359.1 K1.8 B
Very volatile
Selling General Administrative7.8 B7.4 BB
Slightly volatile
Research Development2.6 M2.5 M1.5 M
Slightly volatile
Selling And Marketing Expenses7.8 B7.4 BB
Slightly volatile
Reconciled Depreciation377 K359.1 K98.9 K
Slightly volatile

Aethlon Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow15.4 M14.6 M5.6 M
Slightly volatile
End Period Cash FlowM5.5 M5.1 M
Slightly volatile
Depreciation377 K359.1 K94.3 K
Slightly volatile
Total Cash From Financing Activities1.2 M1.3 M5.2 M
Slightly volatile
Stock Based Compensation1.1 M1.2 M954 K
Pretty Stable
Change To Netincome1.6 M1.1 MM
Slightly volatile
Issuance Of Capital Stock1.3 M1.3 MM
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio14.8515.6347.3556
Slightly volatile
Days Sales Outstanding80.47143113
Slightly volatile
Average Payables792.3 K605.4 K481.8 K
Pretty Stable
Stock Based Compensation To Revenue1.941.652.2394
Pretty Stable
Capex To Depreciation0.860.69872.1495
Pretty Stable
Payables Turnover0.440.4616121
Slightly volatile
Sales General And Administrative To Revenue6.311.777.7307
Slightly volatile
Research And Ddevelopement To Revenue2.264.32.6716
Slightly volatile
Capex To Revenue1.551.480.4511
Slightly volatile
Cash Per Share2.062.165721.9377
Pretty Stable
Days Payables Outstanding417791946
Very volatile
Income Quality0.450.82980.6984
Pretty Stable
Intangibles To Total Assets1.0E-41.0E-40.0813
Slightly volatile
Current Ratio2.153.25045.0818
Slightly volatile
Receivables Turnover2.512.644.173
Slightly volatile
Graham Number15.0515.8385397
Slightly volatile
Capex Per Share0.09480.09980.9421
Slightly volatile
Average Receivables79.7 K57.6 K115.6 K
Slightly volatile
Revenue Per Share0.310.3213.1934
Slightly volatile
Interest Debt Per Share0.00140.001537.0924
Slightly volatile
Debt To Assets0.250.270.9388
Slightly volatile
Days Of Payables Outstanding417791946
Very volatile
Ebt Per Ebit0.920.9661175
Slightly volatile
Quick Ratio3.093.250435.9842
Pretty Stable
Net Income Per E B T1.091.150.9449
Slightly volatile
Cash Ratio2.032.97394.8102
Slightly volatile
Days Of Sales Outstanding80.47143113
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.821.02481.0109
Pretty Stable
Fixed Asset Turnover0.270.29697
Slightly volatile
Debt Ratio0.250.270.9388
Slightly volatile
Price Sales Ratio14.8515.6347.3556
Slightly volatile
Asset Turnover0.03580.03770.5416
Slightly volatile
Operating Cycle106143147
Pretty Stable

Aethlon Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.1 M4.3 M14.2 M
Slightly volatile

Aethlon Fundamental Market Drivers

Forward Price Earnings0.2102
Cash And Short Term Investments5.4 M

Aethlon Upcoming Events

12th of February 2024
Upcoming Quarterly Report
View
26th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of June 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

About Aethlon Medical Financial Statements

Aethlon Medical stakeholders use historical fundamental indicators, such as Aethlon Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aethlon Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aethlon Medical's assets and liabilities are reflected in the revenues and expenses on Aethlon Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aethlon Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue192.8 K183.2 K
Cost Of Revenue359.1 K341.1 K
Stock Based Compensation To Revenue 1.65  1.94 
Sales General And Administrative To Revenue 11.77  6.30 
Research And Ddevelopement To Revenue 4.30  2.26 
Capex To Revenue 1.48  1.55 
Revenue Per Share 0.32  0.31 
Ebit Per Revenue(23.83)(25.02)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.50)
Return On Equity
(1.05)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.